George C. Prendergast
| George C. Prendergast | |
|---|---|
 |
|
| Born | Philadelphia, Pennsylvania |
| Alma mater | Princeton University (PhD) Yale University (MS) University of Pennsylvania (BA) |
| Awards | 1995 Pew Scholar in the Biomedical Sciences |
| Scientific career | |
| Fields | Oncology, Molecular biology, Oncoimmunology |
| Institutions |
Lankenau Institute for Medical Research DuPont Pharmaceuticals Company The Wistar Institute Merck Research Laboratories Howard Hughes Medical Institute |
George C. Prendergast, PhD (born 1961) is an American oncologist and biomedical scientist, currently President and CEO of Lankenau Institute for Medical Research (LIMR); Co-leader of the Program in Cancer Cell Biology & Signaling at Kimmel Cancer Center, Thomas Jefferson University; and Editor-in-Chief of Cancer Research, the most highly cited journal in the field.
Born in Philadelphia, Pennsylvania in 1961, Prendergast graduated from the University of Pennsylvania in 1983 with a BA in Biochemistry. He earned an MS in molecular biophysics from Yale University in 1984 and a PhD in molecular biology from Princeton University in 1989.After receiving his doctorate, Prendergast continued his research as an American Cancer Society postdoctoral fellow at the Howard Hughes Medical Institute at NYU Medical Center.
Prendergast joined the Department of Cancer Research at Merck Research Laboratories as a staff scientist in 1991. In 1993, he returned to academic research at The Wistar Institute in Philadelphia, first as an assistant professor and later as an associate professor and assistant chair of the Tumor Biology Group. While at Wistar, in 1995, Prendergast was designated a Pew Scholar in the Biomedical Sciences.
In 1999, Prendergast left Wistar to become Senior Director of the Cancer Research Group at DuPont Pharmaceuticals Company. After the sale of DuPont Pharmaceuticals to Bristol-Myers Squibb, Prendergast moved his groups at Wistar and DuPont to Lankenau Institute for Medical Research (LIMR) in 2002. He was appointed President and CEO of LIMR in 2004,.
...
Wikipedia